Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07489417 · ClinicalTrials.gov registry record · NA
Impact of Sleep Restriction on Blood Pressure Reactivity
A NA study, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07489417: Recruiting NA study, sponsored by University of Missouri-Columbia.
NCT07489417 is a NA study that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07489417, a NA study, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of the research study is to examine the effects of shortened sleep on blood pressure.
Primary Outcome
Mean Blood pressure
Interventions
- BEHAVIORAL Sleep Restriction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT07489417 shows while recruiting
NCT07489417 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Sleep Restriction is the first listed.
NCT07489417 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07489417 about?
NCT07489417 is a clinical study titled "Impact of Sleep Restriction on Blood Pressure Reactivity". The purpose of the research study is to examine the effects of shortened sleep on blood pressure.
What is the current status of trial NCT07489417?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-03-04. Estimated completion is 2027-08.
What interventions are being tested in trial NCT07489417?
The interventions under investigation include: Sleep Restriction (BEHAVIORAL).
Who is sponsoring clinical trial NCT07489417?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07489417's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI